SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is actively discussing crow with knife ($CAW) with enthusiasm, particularly its multi-chain functionality and burn mechanism. The community frequently mentions 'Wagmi' and highlights $CAW's presence on various blockchains like $SOL, $CRO, and $ETH. Community members emphasize the coin's organic growth and strong community.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses potential breakouts and golden crosses, with some eyeing a rally towards $90 and beyond. There's also chatter about Litecoin's position relative to Bitcoin and other altcoins, and its potential within the broader crypto market. Some traders are closely watching the LTCBTC chart for signals of an upcoming altseason.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining attention as a "culture coin" within the cannabis industry, drawing comparisons to Bitcoin but with a focus on community and organic growth. Discussions revolve around its potential to challenge traditional pharmaceutical models and the benefits of cannabis. The community emphasizes a long-term vision, creativity, and positive contributions within the Web3 space, while establishing itself on the SOL network.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its potential for a significant run, drawing comparisons to recent low-float movers like $SMX and $TGL. Bullish sentiment is fueled by the company's recent announcement of a positive profit outlook, with some anticipating a massive squeeze targeting much higher prices. However, caution is advised due to its history as a Chinese company.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is trending as the community rallies around upcoming "airlock" developments, which are currently undergoing testing. Social media buzz is focused on the coin's potential and opportunities within the low-cap token space. The community highlights the coin's strong CTO and the benefits of HODLing.

Moo Deng

Moo Deng is trending as traders discuss its potential for a significant run, driven by its low market cap and upcoming anniversary; despite recent price rejections and overall crypto market volatility, the community remains optimistic about a potential breakout, with some anticipating a pump.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

$4CHAN is trending as community members highlight its potential as the 'Bitcoin of memecoins,' emphasizing its origins and unique position within internet culture. Discussions revolve around its massive token supply and the community's strong belief in its long-term growth, with some anticipating a significant breakout. The token is perceived as a play on the broader meme economy, particularly with the upcoming 2026 'Meme Supercycle'.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

$IRON is trending due to positive initial data from its RALLY-MF Phase 2 trial, with the community actively discussing the robust hematologic responses to DISC-0974. The bullish sentiment is further fueled by analysts raising price targets and the stock nearing 52-week highs. Community members are anticipating further data releases and speculating on potential price targets.

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015, and is headquartered in Cambridge, MA.

Fulcrum Therapeutics Inc

Fulcrum Therapeutics ($FULC) is trending due to positive data readouts and analyst upgrades, fueling community excitement about its potential in sickle cell disease treatment. Discussions revolve around the promising safety profile and the possibility of accelerated FDA approval. The community highlights that these factors position $FULC as a potential leader in the oral treatment class, offering a convenient and scalable alternative to existing therapies.

SSgA Active Trust - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

The Utilities Select Sector SPDR Fund ($XLU) is trending as it reaches new all-time highs, fueled by enthusiasm around AI-driven power demand and expectations of future rate cuts. Community discussions highlight the sector's role as a defensive play amidst market uncertainty, though some analysts suggest the rally may be overextended. Some are pointing to nuclear as a next catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts

Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the stock, Marketbeat...

Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC

Orchard Capital Management LLC lowered its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 53.9% in the second quarter, according to its most recent Form 13F filing with...

Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX

Jefferies Financial Group Inc. boosted its stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 106.7% during the 2nd quarter, according to its most recent 13F filing with the...

What is Northland Capmk's Estimate for HRTX FY2026 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Capmk issued their FY2026 earnings estimates for Heron Therapeutics in a research report issued to...

What is HC Wainwright's Forecast for HRTX FY2025 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for Heron Therapeutics in a research note...

What is HC Wainwright's Forecast for HRTX FY2027 Earnings?

Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Research analysts at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Heron Therapeutics in a report released on Tuesday...

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -150.00% and -0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -100.00% and -1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Heron Therapeutics Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$1.31
Prev Close	$1.31
Open	$1.29
Dividend Yield	0.00%
50-Day Moving Average	$1.20
Beta	1.41
Avg. Volume	2.2M
PE Ratio	-16.19

52-Week High	$2.68
52-Week Low	$0.9999
Market Capitalization	$240.2M
EPS (Annual)	-$0.0891
Price to Book	34.19
Revenue Per Employee	$1.18M
Enterprise Value/EBITDA	N/A

HRTX
Heron Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HRTX News

HRTXHeron Therapeutics Inc